Intravitreal Voriconazole for the Treatment of Endogenous Aspergillus Endophthalmitis
- 31 July 2006
- journal article
- case report
- Published by Elsevier in Ophthalmology
- Vol. 113 (7) , 1184-1186
- https://doi.org/10.1016/j.ophtha.2006.01.059
Abstract
No abstract availableKeywords
This publication has 17 references indexed in Scilit:
- AspergillusInfections in Transplant RecipientsClinical Microbiology Reviews, 2005
- Voriconazole: therapeutic review of a new azole antifungalExpert Review of Anti-infective Therapy, 2004
- Culture-proven endogenous endophthalmitis: clinical features and visual acuity outcomes*1American Journal of Ophthalmology, 2004
- Newer Systemic Antifungal AgentsDrugs, 2004
- Aspergillus endophthalmitis: an unusual complication of disseminated infection in renal transplant patientsJournal of Infection, 2003
- Endogenous mycotic endophthalmitis: variations in clinical and histopathologic changes in candidiasis compared with aspergillosisAmerican Journal of Ophthalmology, 2001
- Endogenous aspergillus endophthalmitis: Clinical features and treatment outcomesOphthalmology, 1998
- Necrotizing Choroiditis-Retinitis as Presenting Symptom of Disseminated Aspergillosis after Lung TransplantationEuropean Journal of Ophthalmology, 1997
- Amphotericin B: 30 Years of Clinical ExperienceClinical Infectious Diseases, 1990
- Retinal toxicity of amphotericin B in vitrectomised versus non-vitrectomised eyes.British Journal of Ophthalmology, 1986